Literature DB >> 23710557

Expression of SDF-1/CXCR4 axis in bone marrow mesenchymal stem cells derived from rheumatoid arthritis-usual interstitial pneumonia.

George A Margaritopoulos1, Katerina M Antoniou, Ismini Lasithiotaki, Athanasia Proklou, Gianna Soufla, Nikos M Siafakas.   

Abstract

OBJECTIVES: To explore the SDF-1/ CXCR4 axis as driving mechanism of bone marrow mesenchymal stem-cells to the injured lung in patients with rheumatoid arthritis associated usual interstitial pneumonia (RA-UIP).
METHODS: We evaluated the m-RNA expression of SDF-1 and CXCR4 with real-time PCR in bone marrow mesenchymal stem cells of 7 RA-UIP and 10 RA patients without lung involvement.
RESULTS: The axis was not expressed in RA whereas both SDF-1 and CXCR4 were expressed in RA-UIP [1.93 (1.32, 2.00) and 0.008 (0, 0.01)] respectively.
CONCLUSIONS: The development of pulmonary fibrosis in RA may be considered as the key event for the migration of stem cells to the injured lung through the SDF-1/CXCR4 axis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23710557

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  68Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.

Authors:  Yaping Luo; Xinxin Cao; Qingqing Pan; Jian Li; Jun Feng; Fang Li
Journal:  J Nucl Med       Date:  2019-05-17       Impact factor: 10.057

2.  Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT.

Authors:  Qingqing Pan; Xinxin Cao; Yaping Luo; Jian Li; Jun Feng; Fang Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-27       Impact factor: 9.236

3.  Impaired mRNA Expression of the Migration Related Chemokine Receptor CXCR4 in Mesenchymal Stem Cells of COPD Patients.

Authors:  K Karagiannis; A Proklou; E Tsitoura; I Lasithiotaki; C Kalpadaki; D Moraitaki; I Sperelakis; G Kontakis; K M Antoniou; N Tzanakis
Journal:  Int J Inflam       Date:  2017-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.